Related references
Note: Only part of the references are listed.CRISPR-engineered T cells in patients with refractory cancer
Edward A. Stadtmauer et al.
SCIENCE (2020)
Loss of exosomal miR-148b from cancer-associated fibroblasts promotes endometrial cancer cell invasion and cancer metastasis
Bi-Lan Li et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
Characterization of circulating T-, NK-, and NKT cell subsets in patients with colorectal cancer: the peripheral blood immune cell profile
Danielle Krijgsman et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2019)
Stromal Microenvironment Shapes the Intratumoral Architecture of Pancreatic Cancer
Matteo Ligorio et al.
CELL (2019)
Endometrial Tumor Microenvironment Alters Human NK Cell Recruitment, and Resident NK Cell Phenotype and Function
Clara Degos et al.
FRONTIERS IN IMMUNOLOGY (2019)
Mucosal-Associated Invariant T Cells Display Diminished Effector Capacity in Oesophageal Adenocarcinoma
Ashanty M. Melo et al.
FRONTIERS IN IMMUNOLOGY (2019)
CCR5 status and metastatic progression in colorectal cancer
Meggy Suarez-Carmona et al.
ONCOIMMUNOLOGY (2019)
Proteogenomic landscape of squamous cell lung cancer
Paul A. Stewart et al.
NATURE COMMUNICATIONS (2019)
Cancer statistics, 2019
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2019)
Prognostic Impact of Tumor-Infiltrating Lymphocytes and Neutrophils on Survival of Patients with Upfront Resection of Pancreatic Cancer
Rainer C. Miksch et al.
CANCERS (2019)
Statistical Methods for Conditional Survival Analysis
Sin-Ho Jung et al.
JOURNAL OF BIOPHARMACEUTICAL STATISTICS (2018)
Integrative Genome-Wide Analysis of Long Noncoding RNAs in Diverse Immune Cell Types of Melanoma Patients
Lei Wang et al.
CANCER RESEARCH (2018)
CCL2 conditionally determines CCL22-dependent Th2-accumulation during TGF-β-induced breast cancer progression
Palash Kumar Mandal et al.
IMMUNOBIOLOGY (2018)
Pan-cancer deconvolution of tumour composition using DNA methylation (vol 9, 3220, 2018)
Ankur Chakrayarthy et al.
NATURE COMMUNICATIONS (2018)
Comprehensive analysis of the clinical immuno-oncology landscape
J. Tang et al.
ANNALS OF ONCOLOGY (2018)
DNA methylation at enhancers identifies distinct breast cancer lineages
Thomas Fleischer et al.
NATURE COMMUNICATIONS (2017)
DNA methylation and repressive histones in the promoters of PD-1, CTLA-4, TIM-3, LAG-3, TIGIT, PD-L1, and galectin-9 genes in human colorectal cancer
Varun Sasidharan Nair et al.
CLINICAL EPIGENETICS (2017)
Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma
Adrian Ally et al.
CELL (2017)
Genomic and Transcriptomic Features of Response to Anti-PD-1 Therapy in Metastatic Melanoma (vol 165, pg 35, 2016)
Willy Hugo et al.
CELL (2017)
DNA Hypomethylation and Histone Variant macroH2A1 Synergistically Attenuate Chemotherapy-Induced Senescence to Promote Hepatocellular Carcinoma Progression
Michela Borghesan et al.
CANCER RESEARCH (2016)
Genomic Analysis of Immune Cell Infiltrates Across 11 Tumor Types
Michael D. Iglesia et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2016)
Genomic analyses identify molecular subtypes of pancreatic cancer
Peter Bailey et al.
NATURE (2016)
Genomic Analysis of Immune Cell Infiltrates Across 11 Tumor Types
Michael D. Iglesia et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2016)
Comprehensive genomic characterization of head and neck squamous cell carcinomas
Michael S. Lawrence et al.
NATURE (2015)
Multiplatform Analysis of 12 Cancer Types Reveals Molecular Classification within and across Tissues of Origin
Katherine A. Hoadley et al.
CELL (2014)
Prognostic B-cell Signatures Using mRNA-Seq in Patients with Subtype-Specific Breast and Ovarian Cancer
Michael D. Iglesia et al.
CLINICAL CANCER RESEARCH (2014)
ClearCode34: A Prognostic Risk Predictor for Localized Clear Cell Renal Cell Carcinoma
Samira A. Brooks et al.
EUROPEAN UROLOGY (2014)
Comprehensive molecular profiling of lung adenocarcinoma
Eric A. Collisson et al.
NATURE (2014)
GSVA: gene set variation analysis for microarray and RNA-Seq data
Sonja Haenzelmann et al.
BMC BIOINFORMATICS (2013)
CpG island hypermethylation-associated silencing of microRNAs promotes human endometrial cancer
Bi-Lan Li et al.
CANCER CELL INTERNATIONAL (2013)
The Continuum of Cancer Immunosurveillance: Prognostic, Predictive, and Mechanistic Signatures
Jerome Galon et al.
IMMUNITY (2013)
Type I and II Endometrial Cancers: Have They Different Risk Factors?
Veronica Wendy Setiawan et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Integrated genomic characterization of endometrial carcinoma
Gad Getz et al.
NATURE (2013)
Tumor-associated macrophages: functional diversity, clinical significance, and open questions
Subhra K. Biswas et al.
SEMINARS IN IMMUNOPATHOLOGY (2013)
Inferring tumour purity and stromal and immune cell admixture from expression data
Kosuke Yoshihara et al.
NATURE COMMUNICATIONS (2013)
Comprehensive molecular characterization of human colon and rectal cancer
Donna M. Muzny et al.
NATURE (2012)
Comprehensive molecular portraits of human breast tumours
Daniel C. Koboldt et al.
NATURE (2012)
Improved prognostic classification of breast cancer defined by antagonistic activation patterns of immune response pathway modules
Andrew E. Teschendorff et al.
BMC CANCER (2010)
Effects of infiltrating lymphocytes and estrogen receptor on gene expression and prognosis in breast cancer
Alberto Calabro et al.
BREAST CANCER RESEARCH AND TREATMENT (2009)
The Macrophage Colony-Stimulating Factor 1 Response Signature in Breast Carcinoma
Andrew H. Beck et al.
CLINICAL CANCER RESEARCH (2009)
Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
AA Alizadeh et al.
NATURE (2000)
Share Paper
